The company based in Massachusetts(MA)reported a fellin revenue to $0 milion for the year when compared to $144.93 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 7,2023 showed that its revenue is up 100.00% year-over-year.
The company reported basic earnings per share of $0 and diluted earnings per share of $0.
Seres Therapeutics, Inc. operates in the Pharmaceutical Preparations sector.
Related News
